共 50 条
- [43] Can fund shareholding inhibit insufficient R&D input?--Empirical evidence from Chinese listed companies [J]. PLOS ONE, 2021, 16 (03):
- [46] Is the context of R&D narrative contingent on R&D expenses or R&D intensity? Evidence from European biopharmaceutical companies [J]. EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT: A 2025 VISION TO SUSTAIN ECONOMIC DEVELOPMENT DURING GLOBAL CHALLENGES, 2020, : 7626 - 7640
- [47] Diversification, financial performance and firm value: Evidence from listed property companies in China [J]. PROCEEDINGS OF 2005 INTERNATIONAL CONFERENCE ON CONSTRUCTION & REAL ESTATE MANAGEMENT, VOLS 1 AND 2: CHALLENGE OF INNOVATION IN CONSTRUCTION AND REAL ESTATE, 2005, : 997 - 1000
- [48] Financial Characteristic and Disclosure Delay of Annual Report: Evidence from Listed Companies in China [J]. PROCEEDINGS OF THE NINTH INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING MANAGEMENT, 2015, 362 : 817 - 828
- [49] Executive Overconfidence and R&D Expenditure -Empirical Evidence Based on Data of Small and Medium-sized Listed Companies in China [J]. 2010 2ND IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND FINANCIAL ENGINEERING (ICIFE), 2010, : 723 - 727
- [50] Why Don't Companies Borrow? Evidence from China's Listed Companies [J]. 2013 SIXTH INTERNATIONAL CONFERENCE ON BUSINESS INTELLIGENCE AND FINANCIAL ENGINEERING (BIFE), 2014, : 231 - 235